Vaccines and mRNA-based therapies have gained a lot of attention recently due to COVID-19. The Vaccine & mRNA Therapies stream will explore the technical challenges facing the formulation, development, characterization, manufacturing, and supply of next-generation vaccines, mRNA vaccines, mRNA gene therapies, RNAi, and gene therapies. Experts from pharma, biotech, academia, and government labs will convene in Boston in person and virtually to deep dive into the challenges associated with successfully developing and delivering these next-generation therapeutics.

Conferences Include:

Keynote Presentations:

Opportunities to Enhance Vaccine Development and Approval Process: On a Path to More Personalized Vaccinology
John Mattison, Operating Partner/Chief Medical Information Officer, Arsenal Capital Partners

miRNA-Based Logic Circuits Encoded on Self-Amplifying RNA for Highly Specific Cancer Cell Classification
Ron Weiss, PhD, Professor, Biological Engineering, Massachusetts Institute of Technology